Akoya Biosciences Inc (AKYA) Stock Price, Quote & News

Company Profile

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 855 896 8401

Fax: 855 404 0061

Website: www.akoyabio.com

Address:

100 Campus Drive, 6th Floor, Marlborough, United States

Will2ride1 May. 31 at 11:09 PM

$AKYA I like it

0 · Reply

JOHNSTOCKTON973 May. 23 at 12:03 PM

$AKYA LETS GOO😎💪🚀🚀🚀🚀🚀🚀

0 · Reply

oldwisetrader May. 22 at 6:29 PM

$AKYA I was stopped out , good luck

0 · Reply

oldwisetrader May. 22 at 3:58 PM

$AKYA hop on board the train, we are heading to Two land

0 · Reply

JOHNSTOCKTON973 May. 22 at 2:17 PM

$AKYA 😎💪🚀🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

oldwisetrader May. 22 at 1:59 PM

$AKYA the best time ever for a new revised higher cash offer is Friday after market close on 3 day weekend

0 · Reply

oldwisetrader May. 22 at 1:51 PM

$AKYA above 1.37 will squeeze

0 · Reply

Rferrer6 May. 22 at 1:44 PM

$AKYA umm what?

0 · Reply

oldwisetrader May. 22 at 1:44 PM

$AKYA can’t believe this isn’t down today, what wrong

0 · Reply

oldwisetrader May. 21 at 8:40 PM

$AKYA considering it says this stock is 70 percent owned by the insiders I would have to assume a sweet cash offer would be tempting since the insiders own 73 percent of the 50 million outstanding shares ……

0 · Reply

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

May 23, 2025, 2:21 PM EDT - 4 weeks ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

QTRX

May 12, 2025, 4:05 PM EDT - 6 weeks ago

Akoya Biosciences Reports First Quarter 2025 Financial Results

May 7, 2025, 3:46 PM EDT - 6 weeks ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

QTRX

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

QTRX

Apr 29, 2025, 7:00 AM EDT - 2 months ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

QTRX

Apr 24, 2025, 8:00 AM EDT - 2 months ago

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

Apr 24, 2025, 8:00 AM EDT - 2 months ago

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

Apr 23, 2025, 8:00 AM EDT - 2 months ago

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

Apr 14, 2025, 8:00 AM EDT - 2 months ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

QTRX

Apr 7, 2025, 8:15 AM EDT - 2 months ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

QTRX

Apr 2, 2025, 8:00 AM EDT - 3 months ago

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

Mar 24, 2025, 8:00 AM EDT - 3 months ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

QTRX

Mar 17, 2025, 4:00 PM EDT - 3 months ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

QTRX

Mar 17, 2025, 4:00 PM EDT - 3 months ago

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Mar 11, 2025, 8:00 AM EDT - 3 months ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

QTRX

Feb 18, 2025, 3:40 PM EST - 4 months ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

QTRX

Feb 5, 2025, 8:00 AM EST - 4 months ago

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Jan 28, 2025, 6:00 AM EST - 5 months ago

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner

Jan 10, 2025, 7:00 AM EST - 5 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

QTRX

Dec 10, 2024, 8:15 AM EST - 7 months ago

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nov 14, 2024, 9:43 PM EST - 7 months ago

Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:00 PM EST - 7 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 8:30 AM EDT - 8 months ago

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 7, 2024, 8:00 AM EDT - 9 months ago

Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

Oct 3, 2024, 4:00 PM EDT - 9 months ago

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

Aug 5, 2024, 10:19 PM EDT - 11 months ago

Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:00 PM EDT - 11 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results

Jul 15, 2024, 4:00 PM EDT - 1 year ago

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

BNGO CTKB DHR LAB MASS OMIC QGEN

May 17, 2024, 8:36 PM EDT - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:00 PM EDT - 1 year ago

Akoya Biosciences Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

May 6, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

May 2, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Apr 22, 2024, 4:05 PM EDT - 1 year ago

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Apr 5, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider

Mar 4, 2024, 8:17 PM EST - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:05 PM EST - 1 year ago

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Feb 8, 2024, 4:05 PM EST - 1 year ago

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Jan 18, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Jan 10, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D.

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

Dec 20, 2023, 8:05 AM EST - 1 year ago

Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023, 7:45 AM EST - 1 year ago

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Will2ride1 May. 31 at 11:09 PM

$AKYA I like it

0 · Reply

JOHNSTOCKTON973 May. 23 at 12:03 PM

$AKYA LETS GOO😎💪🚀🚀🚀🚀🚀🚀

0 · Reply

oldwisetrader May. 22 at 6:29 PM

$AKYA I was stopped out , good luck

0 · Reply

oldwisetrader May. 22 at 3:58 PM

$AKYA hop on board the train, we are heading to Two land

0 · Reply

JOHNSTOCKTON973 May. 22 at 2:17 PM

$AKYA 😎💪🚀🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

oldwisetrader May. 22 at 1:59 PM

$AKYA the best time ever for a new revised higher cash offer is Friday after market close on 3 day weekend

0 · Reply

oldwisetrader May. 22 at 1:51 PM

$AKYA above 1.37 will squeeze

0 · Reply

Rferrer6 May. 22 at 1:44 PM

$AKYA umm what?

0 · Reply

oldwisetrader May. 22 at 1:44 PM

$AKYA can’t believe this isn’t down today, what wrong

0 · Reply

oldwisetrader May. 21 at 8:40 PM

0 · Reply

DSTOCK80 May. 21 at 8:37 PM

$AKYA watches 324😁

0 · Reply

bzspy May. 21 at 6:14 PM

$DTSS Grab the dips. 100M contract. this one is a sleeper. Accumulation zone. 🔥🔥 $AKYA looking solid. Holding nicely. $LTRY nice run today $MLGO could be consolidating for another leg.

0 · Reply

topstockalerts May. 21 at 4:23 PM

Midday Top Gainers PT2 $EDBL $NAKA $MRM $GOOS $AKYA

0 · Reply

MrTicker May. 21 at 3:53 PM

$AKYA 11:45 AM EDT, 05/21/2025 (MT Newswires) -- Akoya Biosciences(AKYA) said in a Wednesday filing that it received an unsolicited acquisition proposal from an undisclosed third party, which offered $1.40 in cash for each Akoya common share.

0 · Reply

Stockttwits619 May. 21 at 3:19 PM

$GNLN $LGMK if ur bored $AKYA $MTVA $MLGO $

0 · Reply

oldwisetrader May. 21 at 2:30 PM

$AKYA for those new, they already were doing a merger, got an unsolicited offer of cash at 1.40 share which they said in 8k wasn’t good enough ,, so what will the next offer be ??? Best case scenario is a bidding war , one of these next mornings over the next few weeks might be entertaining …

0 · Reply

TheRealShortSqueezy May. 21 at 2:05 PM

$AKYA Needs to break 1.33$ and close above. 1.46 / 1.62$

0 · Reply

DSTOCK80 May. 21 at 2:04 PM

$AKYA pushing

0 · Reply

oldwisetrader May. 21 at 2:01 PM

$AKYA break above 1.33 should squeeze

0 · Reply

kebrik May. 21 at 1:59 PM

Today's movers: $WOK, $BDSX, $AKYA, $HYLN, and $SLXN

0 · Reply

JOHNSTOCKTON973 May. 21 at 1:53 PM

$AKYA LETS GO🚀🚀🚀🚀🚀🚀🚀🚀

0 · Reply

YouGotaDeePlusTrades May. 21 at 1:30 PM

$AKYA $GOOS $SGMA $XPEV You are naming everything that is already up…which is obvious… Are you predicting more bullishness or just reporting what we can all see?

1 · Reply

Market Cap	64.44M
Revenue (ttm)	81.67M
Net Income (ttm)	-55.37M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-67.80%
Debt to Equity Ratio	-12.99

Volume	488,100
Avg Vol	551,818
Day's Range	N/A - N/A
Shares Out	49.95M
Stochastic %K	31%
Beta	1.35
Analysts	Hold
Price Target	$2.13